Device Trial Radar · NCT02775136
An Evaluation of a Non-invasive Brain Monitor
Last checked: Nov 20, 2026Latest source record: Oct 30, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
160
Planned (sponsor's estimate)
Start
Oct 2014
Primary completion
Jun 2017
Study completion Dec 2017
Sponsor
- Lead sponsor
- HeadSense MedicalNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Klinikum Stuttgart; Klinikum Darmstadt; University Medical Center Goettingen
- First posted
- May 17, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
HS-1000 device, a proprietary new non-invasive brain monitor, is expected to safely and accurately monitor physiological signs of the brain with minimal discomfort to patients, providing information about normal or abnormal brain-related conditions and providing decision-making support for physicians. Investigators hypothesis that the HS-1000 is capable of detecting and monitoring various neuropathologies, using the acoustic raw data derived from the noninvasive procedure.
Conditions
- Brain Injuries
- Subarachnoid Hemorrhage
- Vasospasm, Intracranial
- Hydrocephalus
- Brain Neoplasms
Interventions
HS-1000 recordingDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of recordings that correlate to neuropathologyTime frame: up to 1 hour
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Klinikum Darmstadt
Darmstadt, Germany · Recruiting
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.